CARDIO DIAGNOSTICS HOLDINGS (CDIO) Stock Price, Quote, News and Overview
NASDAQ:CDIO - Nasdaq - US14159C1036 - Common Stock - Currency: USD
CDIO Quote, Performance and Key Statistics
0.484
-0.04 (-6.91%)
The current stock price of CDIO is 0.484 USD. In the past month the price increased by 17.13%. In the past year, price decreased by -29.86%.
CDIO Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 18.39 | 329.14B | ||
| AMGN | AMGEN INC | 14.17 | 150.99B | ||
| GILD | GILEAD SCIENCES INC | 13.33 | 128.61B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1702.9 | 126.96B | ||
| REGN | REGENERON PHARMACEUTICALS | 13.2 | 65.88B | ||
| ARGX | ARGENX SE - ADR | 330.52 | 37.54B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.72B | ||
| ONC | BEIGENE LTD-ADR | N/A | 26.39B | ||
| BNTX | BIONTECH SE-ADR | N/A | 24.52B | ||
| NTRA | NATERA INC | N/A | 20.79B | ||
| BIIB | BIOGEN INC | 7.22 | 17.39B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 17.30B |
Related stock screener links
About CDIO
Company Profile
Cardio Diagnostics Holdings, Inc. engages in the provision of medical diagnostic testing services. The company is headquartered in Chicago, Illinois and currently employs 7 full-time employees. The company went IPO on 2021-11-23. The firm develops and commercializes a series of products for various types of cardiovascular disease and associated co-morbidities, including coronary heart disease (CHD), stroke, heart failure and diabetes, by leveraging its artificial intelligence (AI)-driven Integrated Genetic-Epigenetic Engine. Its first product, Epi+Gen CHD, is an epigenetics-based clinical blood test capable of assessing near-term (three-year) risk for CHD, and its second product, PrecisionCHD, is an epigenetics-based clinical blood test for the detection of CHD. CardioInnovate360 is a research use only (RUO) solution to support the discovery, development and validation of biopharmaceuticals for the assessment and management of cardiovascular diseases. HeartRisk is a cardiovascular risk intelligence platform that combines insights from anonymized and aggregated clinical cardiovascular data.
Company Info
CARDIO DIAGNOSTICS HOLDINGS
311 W. Superior Street, Suite 444
Chicago ILLINOIS US
Employees: 8
Company Website: http://www.cardiodiagnosticsinc.com
Investor Relations: https://cardiodiagnosticsinc.com/investors-sec-filings/
Phone: 18552269991
CARDIO DIAGNOSTICS HOLDINGS / CDIO FAQ
What is the stock price of CARDIO DIAGNOSTICS HOLDINGS today?
The current stock price of CDIO is 0.484 USD. The price decreased by -6.91% in the last trading session.
What is the ticker symbol for CARDIO DIAGNOSTICS HOLDINGS stock?
The exchange symbol of CARDIO DIAGNOSTICS HOLDINGS is CDIO and it is listed on the Nasdaq exchange.
On which exchange is CDIO stock listed?
CDIO stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for CARDIO DIAGNOSTICS HOLDINGS stock?
7 analysts have analysed CDIO and the average price target is 2.04 USD. This implies a price increase of 321.49% is expected in the next year compared to the current price of 0.484. Check the CARDIO DIAGNOSTICS HOLDINGS stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is CARDIO DIAGNOSTICS HOLDINGS worth?
CARDIO DIAGNOSTICS HOLDINGS (CDIO) has a market capitalization of 25.24M USD. This makes CDIO a Nano Cap stock.
How many employees does CARDIO DIAGNOSTICS HOLDINGS have?
CARDIO DIAGNOSTICS HOLDINGS (CDIO) currently has 8 employees.
What are the support and resistance levels for CARDIO DIAGNOSTICS HOLDINGS (CDIO) stock?
CARDIO DIAGNOSTICS HOLDINGS (CDIO) has a support level at 0.4 and a resistance level at 0.52. Check the full technical report for a detailed analysis of CDIO support and resistance levels.
Is CARDIO DIAGNOSTICS HOLDINGS (CDIO) expected to grow?
The Revenue of CARDIO DIAGNOSTICS HOLDINGS (CDIO) is expected to grow by 854.55% in the next year. Check the estimates tab for more information on the CDIO EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy CARDIO DIAGNOSTICS HOLDINGS (CDIO) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of CDIO, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of CDIO, evaluating the profitability, health, valuation and growth aspects
- CARDIO DIAGNOSTICS HOLDINGS (CDIO) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- CARDIO DIAGNOSTICS HOLDINGS (CDIO) Sales and EPS estimates to see what analysts future expectations are.
- CARDIO DIAGNOSTICS HOLDINGS (CDIO) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- CARDIO DIAGNOSTICS HOLDINGS (CDIO) Insider and Institutional Ownership to learn about the owners and their transactions.
- CARDIO DIAGNOSTICS HOLDINGS (CDIO) Stock Chart to make your own analysis
- CARDIO DIAGNOSTICS HOLDINGS (CDIO) Latest news and press-releases to stay up to date.
Does CARDIO DIAGNOSTICS HOLDINGS (CDIO) stock pay dividends?
CDIO does not pay a dividend.
When does CARDIO DIAGNOSTICS HOLDINGS (CDIO) report earnings?
CARDIO DIAGNOSTICS HOLDINGS (CDIO) will report earnings on 2025-05-14.
What is the Price/Earnings (PE) ratio of CARDIO DIAGNOSTICS HOLDINGS (CDIO)?
CARDIO DIAGNOSTICS HOLDINGS (CDIO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.33).
What is the Short Interest ratio of CARDIO DIAGNOSTICS HOLDINGS (CDIO) stock?
The outstanding short interest for CARDIO DIAGNOSTICS HOLDINGS (CDIO) is 2.59% of its float. Check the ownership tab for more information on the CDIO short interest.
CDIO Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to CDIO. When comparing the yearly performance of all stocks, CDIO is a bad performer in the overall market: 69.96% of all stocks are doing better.
CDIO Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to CDIO. CDIO scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
CDIO Financial Highlights
Over the last trailing twelve months CDIO reported a non-GAAP Earnings per Share(EPS) of -0.33. The EPS increased by 50% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -78.98% | ||
| ROE | -87.71% | ||
| Debt/Equity | 0.03 |
CDIO Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to CDIO. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 22.73% and a revenue growth 854.55% for CDIO